Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8962830 | Annals of Vascular Surgery | 2018 | 23 Pages |
Abstract
In this small cohort, we failed to show that best medical treatment decreased mortality or CV event rates, but it tended to be associated with decreased additional vascular surgery rate. Further studies taking into consideration the control of CV risk factors could be interesting to demonstrate better outcome from LE-PAD patients with best medical treatment compared with LE-PAD patients without. There is an urgent need for a more effective implementation of currently recommended medication and a continued search after more effective pharmacologic treatment options in LE-PAD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martina Thiney, Nellie Della Schiava, Rene Ecochard, Patrick Feugier, Patrick Lermusiaux, Antoine Millon, Anne Long,